CHMP Backs Bupivacaine/Meloxicam (Zynrelef) for Postop Pain CHMP Backs Bupivacaine/Meloxicam (Zynrelef) for Postop Pain

The CHMPS has recommended granting marketing authorization for the nonopioid drug to treat surgical pain, as well as for a generic form of Fampyra to treat multiple sclerosis associated with walking disability.International Approvals
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Neurology & Neurosurgery News Alert Source Type: news